Cargando…

Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt

BACKGROUND: Newcastle disease is a devastating disease in poultry caused by virulent Newcastle disease virus (NDV), a paramyxovirus endemic in many regions of the world despite intensive vaccination. Phylogenetic analyses reveal ongoing evolution of the predominant circulating genotype 2.VII, and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Moharam, Ibrahim, Asala, Olayinka, Reiche, Sven, Hafez, Hafez, Beer, Martin, Harder, Timm, Grund, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072307/
https://www.ncbi.nlm.nih.gov/pubmed/33902633
http://dx.doi.org/10.1186/s12985-021-01540-0
_version_ 1783683891732676608
author Moharam, Ibrahim
Asala, Olayinka
Reiche, Sven
Hafez, Hafez
Beer, Martin
Harder, Timm
Grund, Christian
author_facet Moharam, Ibrahim
Asala, Olayinka
Reiche, Sven
Hafez, Hafez
Beer, Martin
Harder, Timm
Grund, Christian
author_sort Moharam, Ibrahim
collection PubMed
description BACKGROUND: Newcastle disease is a devastating disease in poultry caused by virulent Newcastle disease virus (NDV), a paramyxovirus endemic in many regions of the world despite intensive vaccination. Phylogenetic analyses reveal ongoing evolution of the predominant circulating genotype 2.VII, and the relevance of potential antigenic drift is under discussion. To investigate variation within neutralization-sensitive epitopes within the protein responsible for receptor binding, i.e. the Hemagglutinin-Neuraminidase (HN) spike protein, we were interested in establishing genotype-specific monoclonal antibodies (MAbs). METHODS: An HN-enriched fraction of a gradient-purified NDV genotype 2.VII was prepared and successfully employed to induce antibodies in BalbC mice that recognize conformationally intact sites reactive by haemagglutination inhibition (HI). For subsequent screening of mouse hybridoma cultures, an NDV-ELISA was established that utilizes Concanavalin A (ConA-ELISA) coupled glycoproteins proven to present conformation-dependent epitopes. RESULTS: Six out of nine selected MAbs were able to block receptor binding as demonstrated by HI activity. One MAb recognized an epitope only present in the homologue virus, while four other MAbs showed weak reactivity to selected other genotypes. On the other hand, one broadly cross-reacting MAb reacted with all genotypes tested and resembled the reactivity profile of genotype-specific polyclonal antibody preparations that point to minor antigenic differences between tested NDV genotpyes. CONCLUSIONS: These results point to the concurrent presence of variable and conserved epitopes within the HN molecule of NDV. The described protocol should help to generate MAbs against a variety of NDV strains and to enable in depth analysis of the antigenic profiles of different genotypes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-021-01540-0.
format Online
Article
Text
id pubmed-8072307
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80723072021-04-26 Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt Moharam, Ibrahim Asala, Olayinka Reiche, Sven Hafez, Hafez Beer, Martin Harder, Timm Grund, Christian Virol J Research BACKGROUND: Newcastle disease is a devastating disease in poultry caused by virulent Newcastle disease virus (NDV), a paramyxovirus endemic in many regions of the world despite intensive vaccination. Phylogenetic analyses reveal ongoing evolution of the predominant circulating genotype 2.VII, and the relevance of potential antigenic drift is under discussion. To investigate variation within neutralization-sensitive epitopes within the protein responsible for receptor binding, i.e. the Hemagglutinin-Neuraminidase (HN) spike protein, we were interested in establishing genotype-specific monoclonal antibodies (MAbs). METHODS: An HN-enriched fraction of a gradient-purified NDV genotype 2.VII was prepared and successfully employed to induce antibodies in BalbC mice that recognize conformationally intact sites reactive by haemagglutination inhibition (HI). For subsequent screening of mouse hybridoma cultures, an NDV-ELISA was established that utilizes Concanavalin A (ConA-ELISA) coupled glycoproteins proven to present conformation-dependent epitopes. RESULTS: Six out of nine selected MAbs were able to block receptor binding as demonstrated by HI activity. One MAb recognized an epitope only present in the homologue virus, while four other MAbs showed weak reactivity to selected other genotypes. On the other hand, one broadly cross-reacting MAb reacted with all genotypes tested and resembled the reactivity profile of genotype-specific polyclonal antibody preparations that point to minor antigenic differences between tested NDV genotpyes. CONCLUSIONS: These results point to the concurrent presence of variable and conserved epitopes within the HN molecule of NDV. The described protocol should help to generate MAbs against a variety of NDV strains and to enable in depth analysis of the antigenic profiles of different genotypes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-021-01540-0. BioMed Central 2021-04-26 /pmc/articles/PMC8072307/ /pubmed/33902633 http://dx.doi.org/10.1186/s12985-021-01540-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Moharam, Ibrahim
Asala, Olayinka
Reiche, Sven
Hafez, Hafez
Beer, Martin
Harder, Timm
Grund, Christian
Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt
title Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt
title_full Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt
title_fullStr Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt
title_full_unstemmed Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt
title_short Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt
title_sort monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for newcastle disease virus genotype 2.vii from egypt
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072307/
https://www.ncbi.nlm.nih.gov/pubmed/33902633
http://dx.doi.org/10.1186/s12985-021-01540-0
work_keys_str_mv AT moharamibrahim monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt
AT asalaolayinka monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt
AT reichesven monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt
AT hafezhafez monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt
AT beermartin monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt
AT hardertimm monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt
AT grundchristian monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt